
ASIA Expertise
Your Partner for Navigating Complex and Dynamic Asian Markets
With deep insights into Asia’s local regulations, stakeholder practices, and evolving trends, we empower healthcare clients to make critical decisions through our strong in-country presence.
Deep Expertise Across Asia
With regional headquarters in Beijing and Shanghai, and a full-time team of 40+ experts, we offer a strong local presence and infrastructure to support clients throughout Asia.
East Asia
- Greater China
- Japan
- South Korea
South Asia & Oceania
- India
- Australia
Southeast Asia
- Singapore
- Malaysia
- Thailand
- Indonesia
- Philippines
- Vietnam

We Understand the Unique Challenges in Asia and Offer a Comprehensive Suite of Strategic Solutions
Challenges in Asia
Competitive Intelligence
- Unique competitive pattern in Asia vs. US and EU
- Fast growing Asian innovative assets impact both local and global markets
Market Access
- Diversified market access challenges & stakeholders
- Complex local pricing and reimbursement consideration and challenges
Market Research
- Country specific EPI pattern and care pathway
- Unique local clinical behavior, adoption rationales, and unmet needs
Policy Impact
- Asian country specific regulation and trends
- Impactful policies reshape the market, e.g. VBP and NRDL evolution in China
BD Assessment
- Asia BD opportunity for local & global commercialization
- The success of deal sourcing and execution requires solid local knowledge of Asia
SAI Med Asia Solutions
- Competitive landscaping and monitoring
- Best practice and industry mitigation strategies
- Analog and benchmarking
- Lifecycle price and revenue strategy and access roadmap
- Key stakeholder mapping and engagements
- Value demonstration and communications
- Market strategy and opportunities forecasting
- Customer behavior analysis and insights
- Omni-channel touchpoints and engagements
- Policy sharing and navigation
- Key stakeholder panel discussion
- Policy strategy and transformation
- Advocacy and policy shaping
- BD opportunity assessment
- Early assets evaluation
- Targeting sourcing and screening
- Outsourcing and deal support
- Local partnerships
Challenges in Asia
SAI Med Asia Solutions
Competitive Intelligence
Challenges in Asia
- Unique competitive pattern in Asia vs. US and EU
- Fast growing Asian innovative assets impact both local and global markets
SAI Med Asia Solutions
- Competitive landscaping and monitoring
- Best practice and industry mitigation strategies
- Analog and benchmarking
Market Access
Challenges in Asia
- Diversified market access challenges & stakeholders
- Complex local pricing and reimbursement consideration and challenges
SAI Med Asia Solutions
- Lifecycle price and revenue strategy and access roadmap
- Key stakeholder mapping and engagements
- Value demonstration and communications
Market Research
Challenges in Asia
- Country specific EPI pattern and care pathway
- Unique local clinical behavior, adoption rationales, and unmet needs
SAI Med Asia Solutions
- Market strategy and opportunities forecasting
- Customer behavior analysis and insights
- Omni-channel touchpoints and engagements
Policy Impact
Challenges in Asia
- Asian country specific regulation and trends
- Impactful policies reshape the market, e.g. VBP and NRDL evolution in China
SAI Med Asia Solutions
- Policy sharing and navigation
- Key stakeholder panel discussion
- Policy strategy and transformation
- Advocacy and policy shaping
BD Assessment
Challenges in Asia
- Asia BD opportunity for local & global commercialization
- The success of deal sourcing and execution requires solid local knowledge of Asia
SAI Med Asia Solutions
- BD opportunity assessment
- Early assets evaluation
- Targeting sourcing and screening
- Outsourcing and deal support
- Local partnerships
We Engage with Regional Stakeholders Across
the Healthcare Landscape
Medical
- PIs, KOLs, and a Broad Range of Physicians
- Hospital Management
- Pharmacists
- Nurses
- Medical Associations
Authority
- Policy Makers and Influencers
- Registration Authorities
- National and Regional Payers
- HTA Experts
Industry
- Pharmaceutical and Bio-tech Players
- Med-tech and IVD Players
- Channel Players: CSOs, Distributors, Retails, etc.
- Service Players: CRO, CDMO/CMO, etc.
- Digital Players: Digital Solution Providers, AI Players, etc.
Patient
- Patients and Caregivers
- Patient Groups
- Patient Related Charity Foundations
Our Strategic Alliances Allow us to Generate Insights
Beyond Traditional Stakeholders
Partnerships with authorities and industry players provide us access to the voices that shape healthcare policy
Policy Interpretation & Industry Execution Assessment
- Partner with China Policy Center
- Advocated by policy think tank
- Address industry players’ hot topics
- Led to a series of panel discussions to explore executional optimization solutions
BeSD Localization to Support China NIP Strategy
- Partner with China CDC and the China Association of Vaccine
- BeSD localization design and execution support
- Optimize national vaccine strategy with evidence support
- Whitepaper and publications